However, a considerable body of evidence suggest that GRPR-targeted imaging might be useful for the non-invasive disease staging and therapy evaluation in ER-positive BC patients, which might be also translated into potential treatment of BC through Peptide Receptor Radioligand Therapy (PRRT) (15, 16). The gene discussed is GRPR; the disease is breast cancer.